MONITORING ANTI-TUBERCULOSIS DRUGS USAGE AMONG PEDIATRIC PATIENTS TO CONTROL TB TRANSMISSION IN FAMILY

Background: Tuberculosis (Tb) is one of main causes of death by infection. One of keys to successful treatment is patient compliance. Medical requires compliance with treatment, compliance Tb treatment is very important, because of transmission risk. This study to analyze determine of monitoring anti-Tb drugs usage among pediatric patients to controlling Tb transmission (TT) in family. Methods: Used quantitative design with an approach cross-sectional. Total sample used sampling where researchers took data from 2019 to 2022 total 155 respondens to control of TT in families of sufferers aged over 5 to 13 years. Survey relying on questionnaire to collecting data. Analyze used Chi-square test with significance level of p < 0.05. Results and Discussions: There were significant relationship between knowledge (p = 0.000; OR = 4.832; 95% CI = 2.415-9.669). Age has significant relationship in controlling TT in family (p = 0.204; OR = 1.621; 95% CI = 0.799-3.287), while family support, prevention level, drugs usage and risk level of transmitting Tb in family have no significant relationship. Anti-Tb drugs usage in pediatric patients to controlling TT in family. Implementing pulmonary Tb transmission program, it needs to be carried out comprehensively and screening of child patients suffering from Tb is also carried out regularly so that rate of reduction in pulmonary Tb is quickly achieved. Conclusions: Handling Tb in children requires cooperation with the patient's family and health workers through an epidemiological approach to infectious diseases to stop the spread of Tb disease. Keywords: anti-tuberculosis drugs usage, pediatric patients, tuberculosis transmission, family